This present evidence may contribute a better understanding of FBXL10 and SNAI1 in metastasis of breast cancer, it may provide a novel therapeutic approach to develop the targeted drugs or inhibitors for the treatment of breast cancer. Here, KDM2B is linked to breast carcinoma.